03/01
Headlines

Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.

Services Sector Losers: Lentuo International (NYSE:LAS), Trans World Entertainment (NASDAQ:TWMC), Hudson Global (NASDAQ:HSON), Nevada Gold & Casinos (NYSEMKT:UWN)

Mark DeFrance02 mins

Lentuo International Inc. (NYSE:LAS) a leading non-state-owned automobile retailer headquartered in Beijing, today announced that it has signed a strategic agreement with China Orient Tiantong Capital Management Ltd. a subsidiary of China Orient Asset Management Corporation, a major state-owned financial asset management company. Lentuo International Inc. (ADR) (NYSE:LAS) stock performance was -5.74% in last session…

Read More

NASDAQ Active Runners: Facebook Inc (NASDAQ:FB), Intel Corporation (NASDAQ:INTC), Plug Power Inc (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL)

Mark DeFrance02 mins

Ever since highly-successful messaging startup WhatsApp was bought out by Facebook Inc (NASDAQ:FB) for $19 billion a few weeks ago, WhatsApp users have been asking for reassurance regarding their privacy after the deal with the social media giant closes. Facebook Inc (NASDAQ:FB) stock performance was 1.51% in last session and finished the day at $68.74….

Read More

Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

Mark DeFrance02 mins

The iShares Biotechnology Indexhas fallen 2.46% in the last month of trading, and biotech stalwarts Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD ) are both down over 8%. What’s most surprising is that Celgene and Gilead are expected to have strong years in terms of earnings and the development of their respective clinical pipelines. Gilead Sciences,…

Read More

Stocks Moving After-Hours: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Kinder Morgan Management (NYSE:KMR), FutureFuel (NYSE:FF)

Mark DeFrance02 mins

Citigroup upgraded it rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to Buy from Neutral after its survey of retinal surgeons indicated the company’s Eylea drug will beat estimates over the near and long term. Citi also believes Regeneron’s pipeline is not adequately reflected in the current share price. The firm raised its price target for the…

Read More
FB Nasdaq FB Facebook

Healthcare Movers: Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Pernix Therapeutics (NASDAQ:PTX), Galena Biopharma (NASDAQ:GALE), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

Mark DeFrance02 mins

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) is lower after the company reported mixed Q4 and full-year 2013 earnings, as well as releasing results for its Phase 3 POISE trial. Shares are now down 10.71% at $412.75, but are still at the higher end of its 52-week range of $30.38 – $497.00 On Friday, Intercept (NASDAQ:ICPT) reported a…

Read More

Most Active Solar Stocks: JA Solar (NASDAQ:JASO), Yingli Green Energy (NYSE:YGE), First Solar (NASDAQ:FSLR), Solar City (NASDAQ:SCTY)

Mark DeFrance03 mins

JA Solar Holdings (NASDAQ:JASO) reached a more than two-year high Monday after reporting Q4 results that beat analyst estimates. The Chinese maker of solar cells reported non-GAAP earnings of RMB 0.94, or $0.16, per diluted ADS, compared with the Capital IQ estimate for a loss of $0.06 a share. Q4 net revenue grew 30% from…

Read More